Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.

Hindi nagbibigay ng serbisyo ang XM sa mga residente ng Estados Unidos.
A
A

AveryDennison

Balita

Reuters - 3 linggo ang nakaraan

U.S. Alphabet, GE Aerospace, Tesla

U.S. RESEARCH ROUNDUP-Alphabet, GE Aerospace, Tesla July 24 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alphabet, GE Aerospace and Tesla, on Wednesday. HIGHLIGHTS * Alphabet Inc GOOGL.O : Piper Sandler raises target price to $206 from $200 * GE Aerospace GE.N : JP Morgan raises target price to $190 from $175 * HCA Healthcare Inc HCA.N : Leerink Partners raises target price to $396 from $367 * Kimberly-Clark Corp
A
A
G
P
T
V
Z
C
T
H
S
A
A
A
A
G
Reuters - 3 linggo ang nakaraan

Avery Dennison Corp reports results for the quarter ended in June - Earnings Summary

Avery Dennison Corp reports results for the quarter ended in June - Earnings Summary Avery Dennison Corp AVY.N reported quarterly adjusted earnings of $2.42​​ per share for the quarter ended in June, higher than the same quarter last year, when the company reported EPS of $1.92. The mean expectation of nine analysts for the quarter was for earnings of $2.26 per share.
A
Reuters - 3 linggo ang nakaraan

Labeling firm Avery Dennison raises full-year profit forecast

Labeling firm Avery Dennison raises full-year profit forecast July 23 (Reuters) - Avery Dennison AVY.N on Tuesday raised the lower end of its full-year earnings per share forecast after posting a higher quarterly profit, benefiting from strong demand for its labeling and packaging products. The company had indicated earlier that its customers were nearly through with destocking inventories built up during the pandemic years.
A
Reuters - 3 linggo ang nakaraan

Avery Dennison Q2 EPS USD 2.18

BRIEF-Avery Dennison Q2 EPS USD 2.18 Jul 23 (Reuters) - Avery Dennison Q2 sales USD 2,235.3 million vs. IBES estimate USD 2,182 million. Q2 net income USD 176.8 million Q2 pretax profit USD 238.4 million
A
Reuters - 3 linggo ang nakaraan

Megacaps report, Harris in frame, China wobbles

MORNING BID AMERICAS-Megacaps report, Harris in frame, China wobbles A look at the day ahead in U.S. and global markets from Mike Dolan Monday's Wall Street bounce saw some relief precede the first two earnings reports from the "Magnificent 7" megacap stocks, while U.S. Vice President Kamala Harris looked set to replace Joe Biden as Democrat candidate for November's White House race.
E
G
G
N
N
S
T
U
V
T
G
J
U
U
U
F
H
S
A
A
G
P
P
Reuters - 4 linggo ang nakaraan

Avery Dennison Corp <AVY.N> expected to post earnings of $2.26 a share - Earnings Preview

Avery Dennison Corp expected to post earnings of $2.26 a share - Earnings Preview Avery Dennison Corp AVY.N , AVY is expected to show a rise in quarterly revenue when it reports results on July 23 for the period ending January 1 0001 The Mentor Ohio-based company is expected to report a 3.8% increase in revenue to $2.171 billion from $2.09 billion a year ago, according to the mean estimate from 9 analysts, based on LSEG data.
A
Reuters - 1 buwan ang nakaraan

Stifel initiates coverage of Avery Dennison with 'buy'

BUZZ-Stifel initiates coverage of Avery Dennison with 'buy' ** Stifel initiates coverage for branding and information solutions provider Avery Dennison AVY.N with 'buy' rating; sets PT of $275 ** Brokerage says AVY maintains a strong balance sheet, providing opportunities for consistent organic reinvestment in the business and bolt-on acquisitions
A
Reuters - 1 buwan ang nakaraan

U.S. Alphabet, Domino's Pizza, McKesson

U.S. RESEARCH ROUNDUP-Alphabet, Domino's Pizza, McKesson July 9 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Alphabet, Domino's Pizza and McKesson, on Tuesday. HIGHLIGHTS * Alphabet Inc GOOGL.O : Jefferies raises target price to $220 from $215 * Domino's Pizza Inc DPZ.N : Baird raises to outperform; raises target to $580 from $530 * McKesson Corp MCK.N : Baird raises target price to $694 from $679 * Teleflex Inc T
A
A
C
C
G
M
C
A
C
T
Reuters - 1 buwan ang nakaraan

U.S. Acelyrin, Blue Owl Capital, Malibu Boats

U.S. RESEARCH ROUNDUP-Acelyrin, Blue Owl Capital, Malibu Boats July 8 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Acelyrin, Blue Owl Capital and Malibu Boats, on Monday. HIGHLIGHTS * Acelyrin Inc SLRN.O : Wells Fargo raises to overweight from equal-weight * Blue Owl Capital Inc OWL.N : TD Cowen cuts to hold from buy * J B Hunt Transport Services Inc JBHT.O : Stephens initiates with overweight rating * Malibu Boat
A
A
C
C
G
G
U
G
A
A
A
A
R
Reuters - 2 buwan ang nakaraan

U.S. Ciena, Huntsman, Prog Holdings

U.S. RESEARCH ROUNDUP-Ciena, Huntsman, Prog Holdings June 7 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ciena, Huntsman and Prog Holdings, on Friday. HIGHLIGHTS * Capital One Financial Corp COF.N : BTIG initiates coverage with neutral rating * Ciena Corp CIEN.N : Raymond James cuts to outperform from strong buy * Collegium Pharmaceutical Inc COLL.O : Jefferies raises to buy from hold * Huntsman Corp HUN.N : JP Mo
A
B
M
D
L
H
L
A
P
R
Reuters - 2 buwan ang nakaraan

Ward Dickson Appointed To Avery Dennison Board

BRIEF-Ward Dickson Appointed To Avery Dennison Board June 3 (Reuters) - Avery Dennison Corp AVY.N : WARD DICKSON APPOINTED TO AVERY DENNISON BOARD OF DIRECTORS Source text for Eikon: ID:nBwVZXm7a Further company coverage: AVY.N
A
Reuters - 3 buwan ang nakaraan

U.S. Chemed, PTC Therapeutics, Regeneron Pharmaceuticals

U.S. RESEARCH ROUNDUP- Chemed, PTC Therapeutics, Regeneron Pharmaceuticals May 21 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Chemed, PTC Therapeutics and Regeneron Pharmaceuticals, on Tuesday. HIGHLIGHTS * Chemed Corp CHE.N : RBC cuts target price to $697 from $712 * Deckers Brands DECK.N : Barclays cuts target price to $1,026 from $1,110 * PTC Therapeutics Inc PTCT.O : Raymond James raises to market perform fro
E
I
J
N
R
D
E
A
K

Kundisyon

Mga Patok na Assets

Disclaimer: Ang mga kabilang sa XM Group ay nagbibigay lang ng serbisyo sa pagpapatupad at pag-access sa aming Online Trading Facility, kung saan pinapahintulutan nito ang pagtingin at/o paggamit sa nilalaman na makikita sa website o sa pamamagitan nito, at walang layuning palitan o palawigin ito, at hindi din ito papalitan o papalawigin. Ang naturang pag-access at paggamit ay palaging alinsunod sa: (i) Mga Tuntunin at Kundisyon; (ii) Mga Babala sa Risk; at (iii) Kabuuang Disclaimer. Kaya naman ang naturang nilalaman ay ituturing na pangkalahatang impormasyon lamang. Mangyaring isaalang-alang na ang mga nilalaman ng aming Online Trading Facility ay hindi paglikom, o alok, para magsagawa ng anumang transaksyon sa mga pinansyal na market. Ang pag-trade sa alinmang pinansyal na market ay nagtataglay ng mataas na lebel ng risk sa iyong kapital.

Lahat ng materyales na nakalathala sa aming Online Trading Facility ay nakalaan para sa layuning edukasyonal/pang-impormasyon lamang at hindi naglalaman – at hindi dapat ituring bilang naglalaman – ng payo at rekomendasyon na pangpinansyal, tungkol sa buwis sa pag-i-invest, o pang-trade, o tala ng aming presyo sa pag-trade, o alok para sa, o paglikom ng, transaksyon sa alinmang pinansyal na instrument o hindi ginustong pinansyal na promosyon.

Sa anumang nilalaman na galing sa ikatlong partido, pati na ang mga nilalaman na inihanda ng XM, ang mga naturang opinyon, balita, pananaliksik, pag-analisa, presyo, ibang impormasyon o link sa ibang mga site na makikita sa website na ito ay ibibigay tulad ng nandoon, bilang pangkalahatang komentaryo sa market at hindi ito nagtataglay ng payo sa pag-i-invest. Kung ang alinmang nilalaman nito ay itinuring bilang pananaliksik sa pag-i-invest, kailangan mong isaalang-alang at tanggapin na hindi ito inilaan at inihanda alinsunod sa mga legal na pangangailangan na idinisenyo para maisulong ang pagsasarili ng pananaliksik sa pag-i-invest, at dahil dito ituturing ito na komunikasyon sa marketing sa ilalim ng mga kaugnay na batas at regulasyon. Mangyaring siguruhin na nabasa at naintindihan mo ang aming Notipikasyon sa Hindi Independyenteng Pananaliksik sa Pag-i-invest at Babala sa Risk na may kinalaman sa impormasyong nakalagay sa itaas, na maa-access dito.

Babala sa Risk: Maaaring malugi ang iyong kapital. Maaaring hindi nababagay sa lahat ang mga produktong naka-leverage. Mangyaring isaalang-alang ang aming Pahayag sa Risk.